Clinical Trial Update: Edinburgh Pain Assessment Tool (EPAT©) Study [NA]

View source ↗

Summary

The Edinburgh Pain Assessment Tool (EPAT©) study for cancer patients has completed, according to the clinical trials registry entry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: University of Edinburgh | Conditions: Cancer | NA | Status: COMPLETED